MAPT and Alzheimer disease: The rationale mentioned is that the symptoms of AD are presumably caused by the gradual accumulation of amyloid β (Aβ) and hyperphosphorylated tau and that disease‐modifying therapies would be most effective if they are started when protein levels in the brain are still low.21, 26, 29, 30